Stonepine Capital Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-351,335
| Closed | -$10.8M | – | 28 |
|
|
2021
Q3 | $10.8M | Sell |
351,335
-58,848
| -14% | -$1.81M | 4.93% | 6 |
|
|
2021
Q2 | $13.3M | Buy |
410,183
+83,491
| +26% | +$2.71M | 6.97% | 5 |
|
|
2021
Q1 | $12.3M | Buy |
326,692
+215,432
| +194% | +$8.14M | 6.67% | 4 |
|
|
2020
Q4 | $5.27M | Sell |
111,260
-76,928
| -41% | -$3.64M | 4.03% | 9 |
|
|
2020
Q3 | $6.07M | Buy |
188,188
+115,183
| +158% | +$3.71M | 6.31% | 5 |
|
|
2020
Q2 | $3.21M | Sell |
73,005
-62,888
| -46% | -$2.77M | 6.23% | 5 |
|
|
2020
Q1 | $4.45M | Buy |
135,893
+94,921
| +232% | +$3.11M | 4.71% | 6 |
|
|
2019
Q4 | $2.09M | Buy |
+40,972
| New | +$2.09M | 1.46% | 17 |
|